NCT05598268 2022-10-28A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors.ImmVira Pharma Co. LtdPhase 1/2 Unknown74 enrolled
NCT03544723 2020-06-09Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.MultiVir, Inc.Phase 2 Unknown40 enrolled